Brief: Flerie's Lipum Selected For EUR 8 Million Horizon Europe Grant
March 10 (Reuters) - Flerie AB FLERIE.ST: FLERIE’S PORTFOLIO COMPANY LIPUM SELECTED FOR EUR 8 MILLION HORIZON EUROPE GRANT FUNDING TO SUPPORT PHASE 2 STUDY OF SOL-116 FOR RHEUMATOID ARTHRITIS Source text: ID:nMFN5n6nlV Further company coverage: FLERIE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen